Finn Egil Skjeldestad
Sunniva Sæbø,
Finn Egil Skjeldestad
:
How have changes in accessibility and public funding influenced contraceptive use among Norwegian adolescents? A cohort study
Finn Egil Skjeldestad,
Mika Gissler,
Reynir Tomas Geirsson,
Anna Heino,
Hildur Björk Sigbjörnsdottir,
Rupali Rajendra Akerkar
m.fl.:
Trends over 50 years with liberal abortion laws in the Nordic countries
Torbjørn Moe Eggebø,
Astrid Rygh,
Brandis Philip Von,
Finn Egil Skjeldestad
:
Prevention of obstetric anal sphincter injuries with perineal support and lateral episiotomy: A historical cohort study
Finn Egil Skjeldestad
:
Minor changes in the incidence of primary and secondary involuntary childlessness across birth cohorts 1916 to 1975, but major differences in treatment success
Amir Rad,
Sveinung Sørbye,
Tormod Brenn,
Sweta Tiwari,
Maja-Lisa Løchen,
Finn Egil Skjeldestad
:
13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25–33 Years with Minor Cytological Abnormalities–6 Years of Follow-Up
Finn Egil Skjeldestad,
Sveinung Sørbye
:
May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia?
Amir Rad,
Sveinung Sørbye,
Sweta Tiwari,
Maja-Lisa Løchen,
Finn Egil Skjeldestad
:
Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015
Merethe Bjørkås,
Finn Egil Skjeldestad
:
Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw
Ingela Lindh,
Finn Egil Skjeldestad,
Oskari Heikinheimo,
Helena Hognert,
Øjvind Lidegaard,
Christina Bergh
m.fl.:
Reproductive changes among women in their 40s: A cross-sectional study
Ingvild Hersoug Nedberg,
Tinatin Manjavidze,
Charlotta Rylander,
Ellen Blix,
Finn Egil Skjeldestad,
Erik Eik Anda
:
Changes in cesarean section rates after introduction of a punitive financial policy in Georgia: A population-based registry study 2017-2019
Lina Grönvall,
Finn Egil Skjeldestad
:
Changed definition of disease and broader screening criteria had little impact on prevalence of gestational diabetes mellitus
Katherrine Ahrens,
Finn Egil Skjeldestad
:
Trends in initiation of hormonal contraceptive methods among teenagers born between 1989 and 1997 in Norway and the United States
Ingvild Hersoug Nedberg,
Marzia Lazzerini,
Ilaria Mariani,
Kajsa Møllersen,
Emanuelle Pessa Valente,
Erik Eik Anda
m.fl.:
Changes in maternal risk factors and their association with changes in cesarean sections in Norway between 1999 and 2016: A descriptive population-based registry study
Tinatin Manjavidze,
Erik Eik Anda,
Karin Charlotta Maria Rylander,
Finn Egil Skjeldestad,
Nata Kazakhashvili
:
The impact of antenatal care utilization on admissions to neonatal intensive care units and perinatal mortality in Georgia
PLOS ONE 2020 DOI
Tinatin Manjavidze,
Erik Eik Anda,
Karin Charlotta Maria Rylander,
Finn Egil Skjeldestad,
Nata Kazakhashvili
:
Unattended Pregnancies and Perinatal Mortality in Georgia
Risk Mangement and Healthcare Policy 2020 DOI
Bjørn Holdø,
Kajsa Møllersen,
Margareta Verelst,
Ian Milsom,
Rune Svenningsen,
Finn Egil Skjeldestad
:
Surgeon’s experience and clinical outcome after retropubic tension‐free vaginal tape—A case series
Mathilde Seeger Bjørnerem,
Sveinung Sørbye,
Finn Egil Skjeldestad
:
Recurrent disease after treatment for cervical intraepithelial neoplasia-The importance of a flawless definition of residual disease and length of follow-up
Tinatin Manjavidze,
Charlotta Rylander,
Finn Egil Skjeldestad,
Nata Kazakhashvili,
Erik Eik Anda
:
Unattended Pregnancies and Perinatal Mortality in Georgia
Ingvild Hersoug Nedberg,
Charlotta Rylander,
Finn Egil Skjeldestad,
Ellen Blix,
Tamar Ugulava,
Erik Eik Anda
:
Factors Associated with Cesarean Section among Primiparous Women in Georgia: A Registry-based Study
Tinatin Manjavidze,
Charlotta Rylander,
Finn Egil Skjeldestad,
Nata Kazakhashvili,
Erik Eik Anda
:
The impact of antenatal care utilization on admissions to neonatal intensive care units and perinatal mortality in Georgia
Tinatin Manjavidze,
Erik Eik Anda,
Karin Charlotta Maria Rylander,
Finn Egil Skjeldestad,
Nata Kazakhashvili
:
Incidence and Causes of Perinatal Mortality in Georgia
Journal of Epidemiology and Global Health (JEGH) 2019 DOI
Bjørn Westre,
Anita Giske,
Hilde Guttormsen,
Sveinung Sørbye,
Finn Egil Skjeldestad
:
Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study
Elisabeth Ludvigsen,
Finn Egil Skjeldestad
:
Station of the fetal head at complete cervical dilation impacts duration of second stage of labor
Bjørn Holdø,
Margareta Verelst,
Rune Svenningsen,
Ian Milsom,
Finn Egil Skjeldestad
:
The retropubic tension-free vaginal tape procedure—Efficacy, risk factors for recurrence and long-term safety
Thomas Bergholt,
Finn Egil Skjeldestad,
Aura Pyykönen,
Steen C. Rasmussen,
Anna-Maija Tapper,
Ragnheiður I. Bjarnadóttir
m.fl.:
Maternal age and risk of cesarean section in women with induced labor at term—A Nordic register‐based study
Tinatin Manjavidze,
Charlotta Rylander,
Finn Egil Skjeldestad,
Nata Kazakhashvili,
Erik Eik Anda
:
Incidence and causes of perinatal mortality in Georgia
Julie Ekman,
Finn Egil Skjeldestad
:
Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study
Ingvild Roksvaag,
Finn Egil Skjeldestad
:
Decreasing trends in number of depot medroxyprogesterone acetate starters in Norway - a cross-sectional study
Janne Rossen,
Kari Klungsøyr,
Susanne Albrechtsen,
Ellen Løkkegård,
Steen Rasmussen,
Thomas Bergholt
m.fl.:
Can oxytocin augmentation modify the risk of epidural analgesia by maternal age in cesarean sections?
Liv Reidun Tverelv,
Sveinung Sørbye,
Finn Egil Skjeldestad
:
Risk for cervical intraepithelial neoplasia grade 3 or higher in follow-up of women with a negative cervical biopsy
Journal of Lower Genital Tract Disease 2018 DOI
Helena Hognert,
Finn Egil Skjeldestad,
Kristina Gemzell-Danielsson,
Oskari Heikinheimo,
Ian Milsom,
Øjvind Lidegaard
m.fl.:
Ecological study on the use of hormonal contraception, abortions and births among teenagers in the Nordic countries
Torbjørn Moe Eggebø,
Astrid Rygh,
P. von Brandis,
Finn Egil Skjeldestad
:
Sammenhengen mellom sfinkterskade, episiotomi og risikofaktorer kjent før fødselen
2023
Torbjørn Moe Eggebø,
Astrid Rygh,
Philip von Brandis,
Finn Egil Skjeldestad
:
Langvarig nytte av det finske konsept for perineal støtte
2023
Thomas Bergholt,
Finn Egil Skjeldestad,
Ellen Løkkegaard
:
Providing relevant information to pregnant women about induction of labor at term is essential. A Reply
Acta Obstetricia et Gynecologica Scandinavica 2020 DOI
Sveinung Wergeland Sørbye,
Finn Egil Skjeldestad
:
Importance of triage for HPV DNA positive women with a 7 HPV genotypes mRNA E6/E7 test
2019
Sveinung Wergeland Sørbye,
Finn Egil Skjeldestad
:
Risk of CIN3+ in post-colposcopy follow-up of women with a negative cervical biopsy
2019
Finn Egil Skjeldestad,
Sveinung Wergeland Sørbye
:
Follow-up after treatment for CIN
2019
Finn Egil Skjeldestad,
Sveinung Wergeland Sørbye
:
Prevalence and HPV genotype distribution in cervical cancer
2019
Finn Egil Skjeldestad
:
Vi mangler en aktiv prevensjonsdebatt i Norge.
03. april 2019
Finn Egil Skjeldestad
:
Lager p-pille som bare skal tas en gang i måneden.
18. desember 2019
Finn Egil Skjeldestad
:
Det er tryggest å droppe mensen når du går på p-piller.
29. mars 2019
Finn Egil Skjeldestad,
Julie Ekman
:
Prescribing COCs to starters - do gynecologists comply with guidelines?
2018
Bjørn Holdø,
Margareta Verelst,
Rune Svenningsen,
Iam Milsom,
Finn Egil Skjeldestad
:
Tension-free vaginal tape – clinical outcomes and risk factors for recurrence
2018
Finn Egil Skjeldestad,
Sveinung W Sørbye,
Marte Slettebakk
:
HPV-test in triage of ASC-US / LSIL - The CIN3+ risk in 5-type HPV E6/E7 mRNA. negative women
2018
Finn Egil Skjeldestad,
Sveinung Wergeland Sørbye,
Reidun Tverelv
:
Risk for CIN3+ in women with a negative cervical biopsy
2018
Finn Egil Skjeldestad,
Bjørn Westre,
Anita Giske,
Hilde Guttormsen,
Sveinung Wergeland Sørbye
:
The added value of rescreening cytology normal samples with positive HPV mRNA test for the detection of CIN2+ in primary screening
2018
Sveinung Wergeland Sørbye,
Liv Helen Hansen,
Finn Egil Skjeldestad
:
Is con-testing with a 3-type HPV mRNA test better strategy for women 21-29 years than cytology alone?
2018
Finn Egil Skjeldestad,
Sveinung Wergeland Sørbye,
Marte Slettebakk
:
HPV-test in triage of ASC-US / LSIL – The CIN3+
risk in 5-type HPV E6/E7 mRNA negative women
2018
Sveinung Wergeland Sørbye,
Liv Helen Hansen,
Finn Egil Skjeldestad
:
A risk-based approach: Co-testing 34612 owmen with cytology and 3-type HPV mRNA test
2018
Finn Egil Skjeldestad,
Amir Rad,
Sveinung Wergeland Sørbye,
Siri Hovland
:
Primary cervical cancer screening with a 5-type HPV E6/E7 mRNA test: Results of 10 years follow-up
2018
De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →